Roland X. Stroobandt

Efficacy and safety of intravenous sotalol for termination of paroxysmal supraventricular tachycardia

Abstract A double-blind, placebo-controlled, crossover, multicenter study was conducted to study the efficacy and safety of a single intravenous dose of sotalol (1.5 mg/kg over 10 minutes) in achieving normal sinus rhythm in paroxysmal supraventricular tachycardia (SVT) lasting ≥15 minutes. Patients were randomized to either sotalol or placebo as initial treatment, and if the SVT was not terminated a crossover was performed after 20 minutes. A total of 43 patients were enrolled, 38 of whom with spontaneous (n = 14) or induced (n = 24) SVT were analyzed for sotalol efficacy. Most patients (n = 27) had atrioventricular (AV) nodal reentrant tachycardia, and an important subgroup (n = 11) had circus movement tachycardia, using an accessory pathway for retrograde conduction. The number of patients converting to sinus rhythm as a result of the initial treatment was significantly higher in the sotalol group than in the placebo group, for spontaneous (p For sotalol safety analysis, 42 patients were included. A total of 37 patients received sotalol, 19 as the first treatment, and 18 as the second treatment, while 25 patients received placebo. A total of 15 possible adverse effects were reported, occurring in 10 patients with sotalol versus 4 with placebo. The only severe side effect (hypotension) necessitating termination of drug administration occurred with placebo. No proarrhythmic effects were observed. The intravenous administration of sotalol appears to be safe and effective for acute termination of supraventricular reentrant tachycardia.

Variability in interpretation of the electrocardiogram in young athletes: an unrecognized obstacle for electrocardiogram-based screening protocols.

AIMS To assess in young athletes (i) the variability in the percentage of abnormal electrocardiograms (ECGs) using different criteria and (ii) the variability in ECG interpretation among cardiologists and sport physicians. METHODS AND RESULTS Electrocardiograms of 138 athletes were categorized by seven cardiologists according to the original European Society of Cardiology (ESC) criteria by Corrado (C), subsequently modified by Uberoi (U), Marek (M), and the Seattle criteria (S); seven sports physicians only used S criteria. The percentage of abnormal ECGs for each physician was calculated and the percentage of complete agreement was assessed. For cardiologists, the median percentage of abnormal ECGs was 14% [interquartile range (IQR) 12.5-20%] for C, 11% (IQR 9.5-12.5%) for U [not significant (NS) compared with C], 11% (IQR 10-13%) for M (NS compared with C), and 7% (IQR 5-8%) for S (P < 0.005 compared with C); complete agreement in interpretation was 64.5% for C, 76% for U (P < 0.05 compared with C), 74% for M (NS compared with C), and 84% for S (P < 0.0005 compared with C). Sport physicians classified a median of 7% (IQR 7-11%) of ECGs as abnormal by S (P = NS compared with cardiologists using S); complete agreement was 72% (P < 0.05 compared with cardiologists using S). CONCLUSION Seattle criteria reduced the number of abnormal ECGs in athletes and increased agreement in classification. However, variability in ECG interpretation by cardiologists and sport physicians remains high and is a limitation for ECG-based screening programs.

A Reappraisal of Pacemaker Timing Cycles Pertaining to Automatic Mode Switching

Automatic mode switching algorithms of dual chamber pacemakers require fundamental changes in the operation of pacemaker timing cycles to optimize detection of supraventricular tachyarrhythmias. The timing cycles related to mode switching are basically independent of the algorithm design. Blanking periods (when the sensing amplifier is temporarily disabled) should be optimized to a relatively small fraction of the pacing cycle to enhance atrial sensing and prevent far-field sensing. This review explains the function of the timing cycles pertaining to mode switching and proposes simpler terminology to facilitate the understanding of pacemaker function and electrographic interpretation of complex recordings.

Simultaneous Recording of Atrial and Ventricular Monophasic Action Potentials: Monophasic Action Potential Duration During Atrial Pacing, Ventricular Pacing, and Ventricular Fibrillation

A newly developed transvenous suction electrode was used in dogs to record monophasic action potentials (MAPs) from the right atrium and right ventricle simultaneously. Continuous MAP recordings could be made from the same endocardial site for test periods of 1.5 hours. Left ventricular pacing at increasing heart rates resulted in a statistically significant decrease of right ventricular MAP duration. A high degree of correlation was found between right ventricular MAP duration at 90% of repolarization and the QT interval during both right atrial and left ventricular pacing. At the onset of ventricular fibrillation (VF), right ventricular MAP duration shortened to 25% of the value obtained during left ventricular pacing at a cycle length of 250 ms. A cyclic alternation in amplitude of the right ventricular MAPs was observed during VF. Fast Fourier Transform Analysis of right ventricular MAPs during VF showed a significant dominant frequency at 12 Hz, with no levels of interest beyond this frequency. This observation might prove to be useful in elaborating a new algorithm for the automatic detection of ventricular fibrillation.

Prediction of Wenckebach behavior and block response in DDD pacemakers.

At higher atrial rates, the behavior of a DDD pulse generator will depend on the atrial rate or spontaneous atrial interval (SAI) and the settings of the pacemaker: upper rate interval (URI), atrioventricular interval (AVI), and atrial refractory interval (ARI). An algorithm was developed enabling the prediction of the degree of Wenckebach block using the parameters mentioned above. In the absence of the programmed settings of the pacemaker, these parameters can be determined by noninvasive methods. AVI can be measured by application of a magnet over the pulse generator, while URI and ARI can be estimated during chest wall stimulation by progressively increasing the frequency of the external extrastimuli. The use of the formula in combination with chest wall stimulation allows the evaluation of the proper functioning of any DDD pacemaker during exercise and in patients with atrial rhythm disturbances, even when no information about the pacemaker settings is available.

Pacing and sensing: how can one electrode fulfill both requirements?

Pacing and sensing are two different functions which can be accomplished by one and the same electrode. Optimal pacing requires a high tissue resistance in order to minimize the stimulation energy, making a small surface electrode highly desirable. For adequate sensing, however, the tissue resistance should be as low as possible which requires a larger electrode surface area. Decreasing the electrode surface area results in an increased polarization impedance. As this latter should he low for both pacing and sensing, an electrode with a large surface area should be used. How can these opposing needs be met by one electrode? The combination of a small geometrical surface and a large porous microstructure along with the choice of low polarizable materials meets both the requirements of pacing and sensing.

Dissimilar ventricular rhythms: implications for ICD therapy.

Sensing of left ventricular (LV) activity in some devices used for cardiac resynchronization therapy (CRT) was designed primarily to prevent the delivery of an LV stimulus into the LV vulnerable period. Such a sensing function of the LV channel is not universally available in contemporary CRT devices. Recordings of LV electrograms may provide special diagnostic data unavailable solely from the standard right ventricular electrogram and corresponding marker channel. We used the LV sensing function of Biotronik CRT defibrillators to find 3 cases of dissimilar ventricular rhythms or tachyarrhythmias. Such arrhythmias are potentially important because concomitant slower right ventricular activity may prevent or delay implantable cardioverter-defibrillator therapy for a life-threatening situation involving a faster and more serious LV tachyarrhythmia. Dissimilar ventricular rhythms may not be rare and may account for cases of unexplained sudden death with a normally functioning implantable cardioverter-defibrillator and no recorded terminal arrhythmia.

Pacemaker-mediated tachycardia initiated by an atrioventricular search algorithm to minimize right ventricular pacing

We report the initiation of pacemaker-mediated tachycardia by a St Jude implantable cardioverter-defibrillator with a programmed Ventricular Intrinsic Preference algorithm used for minimizing or inhibiting right ventricular pacing. This feature prolongs the atrioventricular (AV) delay periodically to determine if ventricular sensed events follow atrial events. Retrograde ventriculoatrial conduction and pacemaker-mediated tachycardia were initiated by long extended AV delays of 300 and 400 milliseconds. The 400-millisecond AV delay consisted of the programmed sensed AV delay (100 milliseconds) plus the Ventricular Intrinsic Preference increment (200 milliseconds) plus 100 milliseconds imposed by the AutoCapture algorithm when it detected loss of ventricular capture.

Different Methods to Measure QRS Duration in CRT Patients: Impact on the Predictive Value of QRS Duration Parameters.

Measurements of QRS duration (QRSD) in patients undergoing cardiac resynchronization therapy (CRT) are not standardized. We hypothesized that both the measurement of QRSD and its predictive value on CRT response are sensitive to the method by which QRSD is measured.

Novel Algorithmic Methods in Mapping of Atrial and Ventricular Tachycardia

Background—Conventional methods to assess local activation time (LAT) detect the peak of the bipolar electrogram (B-LATPeak) or the maximal negative slope of the unipolar electrogram (U-LATSlope). We evaluated 3 novel methods to assess LAT: onset (B-LATOnset) and center of mass (B-LATCoM) of bipolar electrogram, and maximal negative slope of unipolar electrogram within a predefined bipolar window (U-LATSlope-hybrid). Methods and Results—In 1753 atrial tachycardia and 1426 ventricular tachycardia recordings, the performance of the methods in detecting LAT was evaluated pair-wise (eg, B-LATPeak versus B-LATOnset). For each comparison, histogram analysis of the differences in LAT values was performed. Variation in differences (P95-P5) in low quality (LQ) was compared with high-quality electrograms. In a separate data set (12 atrial tachycardia and 10 ventricular tachycardia), we evaluated for each method the accuracy in algorithmic activation mapping. Both in atrial tachycardia and ventricular tachycardia, the variation in difference between the conventional and novel methods was larger in LQ electrograms. In contrast, variation in difference between the novel methods was comparable in LQ and high-quality electrograms. Except for LATSlope-hybrid, all methods showed decreased mapping accuracy with increasing percentage of LQ electrograms. U-LATSlope-hybrid accurately mapped activation in 16 out of 22 maps (versus B-LATCoM, 14; B-LATPeak, 14; B-LATOnset, 13; U-LATSlope, 4). Conclusions—In LQ atrial and ventricular electrograms, the novel LAT methods (B-LATOnset, B-LATCoM, and U-LATSlope-hybrid) show less variation than the conventional methods. The U-LATSlope-hybrid, a hybrid method that accurately detects the maximal negative unipolar slope, is associated with the highest accuracy in algorithmic mapping of atrial tachycardia/ventricular tachycardia.